Results 271 to 280 of about 105,016 (295)
Some of the next articles are maybe not open access.
Membranous Nephropathy and Malignancy
Seminars in Nephrology, 2010An association between the glomerular disease membranous nephropathy (MN) and malignancy has long been appreciated, but evidence supporting this relationship remains limited, speculative, and, at times, controversial. Reports that the two disease processes often evolve in parallel, as well as the occasional findings of tumor antigens or tumor-reactive ...
openaire +2 more sources
Management of membranous nephropathy
Nephrology, 2000SUMMARY: The Management of membranous nephropathy requires a recognition of its natural history and an ability to predict those pationts with the worst prognosis. Treatment of those at risk of progression with immunosuppressive drugs should be accompanied by additional conservative risk reduction strategies such as dietary protein restriction, blood ...
openaire +2 more sources
NELL1 is a target antigen in malignancy-associated membranous nephropathy
Kidney International, 2021Daniel Kenan +2 more
exaly
Clinical Membranous Nephropathy
Nephron, 2008N P, Mallick, C D, Short, J, Manos
openaire +2 more sources
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
Nature Reviews Nephrology, 2022Linda Reinhard +2 more
exaly
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
Kidney International Reports, 2021Jack F M Wetzels +2 more
exaly
Pathogenesis of membranous nephropathy: recent advances and future challenges
Nature Reviews Nephrology, 2012Pierre Ronco, Hanna Debiec
exaly